1. Home
  2. TOMZ vs HCWB Comparison

TOMZ vs HCWB Comparison

Compare TOMZ & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TOMI Environmental Solutions Inc.

TOMZ

TOMI Environmental Solutions Inc.

HOLD

Current Price

$0.80

Market Cap

12.5M

Sector

Finance

ML Signal

HOLD

HCWB

HCW Biologics Inc.

HOLD

Current Price

$1.28

Market Cap

14.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOMZ
HCWB
Founded
1979
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.5M
14.8M
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
TOMZ
HCWB
Price
$0.80
$1.28
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$35.00
AVG Volume (30 Days)
349.3K
26.1M
Earning Date
05-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
13.64
N/A
EPS
N/A
0.37
Revenue
$5,635,927.00
$4,099,750.00
Revenue This Year
$48.56
N/A
Revenue Next Year
$121.37
N/A
P/E Ratio
N/A
$3.27
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.25
52 Week High
$1.20
$7.35

Technical Indicators

Market Signals
Indicator
TOMZ
HCWB
Relative Strength Index (RSI) 44.37 46.22
Support Level $0.69 $1.03
Resistance Level $0.82 $1.26
Average True Range (ATR) 0.10 0.33
MACD -0.02 -0.14
Stochastic Oscillator 21.84 4.60

Price Performance

Historical Comparison
TOMZ
HCWB

About TOMZ TOMI Environmental Solutions Inc.

TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. The product portfolio of the company includes The SteraPak, The Surface Unit, SteraMist Transport, The NV+, The Environment System, and others.

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

Share on Social Networks: